Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier)
Melanie Guendert et al.
GUT (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault et al.
GUT (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Tbx20 Is Required in Mid-Gestation Cardiomyocytes and Plays a Central Role in Atrial Development
Cornelis J. Boogerd et al.
CIRCULATION RESEARCH (2018)
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
Muriel X. G. Draht et al.
CLINICAL EPIGENETICS (2018)
Genome-wide methylation analysis identifies novel prognostic methylation markers in colon adenocarcinoma
Weinan Xue et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
DNA methylation markers for diagnosis and prognosis of common cancers
Xiaoke Hao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
Weilin Pu et al.
CLINICAL EPIGENETICS (2017)
Waste, Leaks, and Failures in the Biomarker Pipeline
John P. A. Ioannidis et al.
CLINICAL CHEMISTRY (2017)
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis
Liang Zong et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Yoshinaga Okugawa et al.
GASTROENTEROLOGY (2015)
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
Muhammad A. Alvi et al.
ONCOTARGET (2015)
The UCSC Cancer Genomics Browser: update 2015
Mary Goldman et al.
NUCLEIC ACIDS RESEARCH (2015)
Methylation of cell-free circulating DNA in the diagnosis of cancer
Kristina Warton et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
De novo identification of differentially methylated regions in the human genome
Timothy J. Peters et al.
EPIGENETICS & CHROMATIN (2015)
Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
Y. Y. Juo et al.
ANNALS OF ONCOLOGY (2014)
CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
Arjen H. G. Cleven et al.
CLINICAL CANCER RESEARCH (2014)
Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells
Chun-Hao Lu et al.
GLYCOBIOLOGY (2014)
Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinoma
Ines Chaar et al.
TUMOR BIOLOGY (2014)
DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients
Torbjorn K. Nilsson et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Evaluating incremental values from new predictors with net reclassification improvement in survival analysis
Yingye Zheng et al.
LIFETIME DATA ANALYSIS (2013)
DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma
Takashi Sato et al.
PLOS ONE (2013)
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
Paul Blanche et al.
STATISTICS IN MEDICINE (2013)
Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array
Roderick C. Slieker et al.
EPIGENETICS & CHROMATIN (2013)
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Felipe de Sousa e Melo et al.
CELL STEM CELL (2011)
Predicting Survival After Curative Colectomy for Cancer: Individualizing Colon Cancer Staging
Martin R. Weiser et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Epigenome-wide association studies for common human diseases
Vardhman K. Rakyan et al.
NATURE REVIEWS GENETICS (2011)
DNA methylation markers in colorectal cancer
Myoung Sook Kim et al.
CANCER AND METASTASIS REVIEWS (2010)
Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Koichi Yagi et al.
CLINICAL CANCER RESEARCH (2010)
MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer
Takatoshi Matsuyama et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K. Maunakea et al.
NATURE (2010)
DNA methylation markers and early recurrence in stage I lung cancer
Malcolm V. Brock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response
Kim M. Smits et al.
PHARMACOGENOMICS (2008)
β2-chimaerin in cancer signaling -: Connecting cell adhesion and MAP kinase activation
Stephen P. Bruinsma et al.
CELL CYCLE (2007)
Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas
H. Judson et al.
JOURNAL OF PATHOLOGY (2006)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Mucins and mucin binding proteins in colorectal cancer
JC Byrd et al.
CANCER AND METASTASIS REVIEWS (2004)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)